A Variety of Diagnostic
Solutions
Revolutionizing the brain health standard of care, we deliver neurodiagnostic capabilities directly to clinicians with a user-friendly and safe imaging device, for early detection, differential diagnosis and treatment prediction of neurodegenerative diseases.
FDA Breakthrough Designation in Stroke and Dementia Diagnosis
Delphi-MD was granted a Breakthrough Designation Medical Device status for the detection of patients at risk for Stroke and Dementia.
FDA Breakthrough Designation for NPH Diagnosis
Delphi-MD was Granted a Breakthrough Designation Medical Device for the Diagnosis of NPH and Prediction of Shunt Treatment Response.
For Physicians
Diagnose patients’ neurodegeneration while it is still treatable
Enable early and improved diagnosis
Attain differential diagnosis through neurophysiological measurement
Leverage objective data for informed decisions
Provide personalized patient care
Receive instant actionable recommendations report
Enable higher patient compliance
Generate additional revenue
For Healthcare Systems and Payors
Accessable, cost-effective and non-invasive brain health diagnosis
The use of Delphi-MD provides highly accurate, non-invasive brain diagnosis of neurodegenerative diseases. Delphi-MD helps healthcare systems and payors improve brain healthcare outcomes and offers patients a one-of-a-kind functional imaging test, promoting preventative care and treatment while reducing financial burden.
Improved risk adjustment
Improve patient experience and wellbeing
Neurodiagnosis Done Right
